rollercoaster

While many of us were excited with the $30 SP (0.03c pre consolidation) and many others are sitting in the corner shaking with their $180 (0.18c pre consolidation) buy in.......and all the talk of the $100 - 1000 upside SP.......the current down turn in SP is not too much of a surprise.....

Yes, we have a potential world changing product, in a lucrative (and competitive and established) market that will take considerable financial investment to have a commercial product (if we arent bought out or taken over)....

Just thinking of the impending events and the 'anticipated' change in SP

Feel free to comment and or add your own.

AS I see it, the release of the 12 month data from the first 5 patients (and the 6 month data from the 2nd group of patients) due next month may attract interest.
Following this, the release of the final 8 patients in the study in around June may also attract attention (being reporting of the study as per the study protocol) and hopefully, publication in a scientific journal will also see some sit up and take notice.
Following that, the study results and publication will assist to the submission of TGA/FDA application and approval, and the commencement of the next trial and provide further support to commercialization of the product.

This could take up to 2 years from now (maybe longer) so, strapping in for what could be a bumpy ride with a potential spectacular end.